Fear of Cancer Recurrence and Coping Strategies among Prostate Cancer Survivors: A Qualitative Study

Author:

Mardani Abbas1ORCID,Farahani Mansoureh Ashghali1,Khachian Alice1,Vaismoradi Mojtaba23ORCID

Affiliation:

1. Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran 1449614535, Iran

2. Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway

3. Faculty of Science and Health, Charles Sturt University, Orange, NSW 2800, Australia

Abstract

Background: Fear of cancer recurrence (FCR), as a commonly reported problem among prostate cancer survivors, has not been fully understood. This study aimed to explore the experience of FCR and relevant coping strategies among Iranian prostate cancer survivors. Methods: Qualitative research was conducted on 13 men who completed treatments for prostate cancer in the last 24 months. The participants were selected through purposeful sampling, and in-depth semi-structured interviews were used for data collection. Conventional content analysis was used for data analysis. Results: Data analysis led to the emergence of three themes. “Living with insecurity” describes the participants’ experiences regarding what triggers FCR with two categories, including “fear of incomplete cure” and “fear of cancer return.” In addition, “struggling to cope” with two categories, including “psychological strategies” and “spiritual coping,” presents coping strategies used by the participants for reducing FCR. Furthermore, “trying to prevent cancer recurrence” with two categories, “seeking health” and “lifestyle modification,” indicates coping strategies used by the participants to prevent cancer recurrence. Conclusions: Healthcare providers need to consider the cultural characteristics of prostate cancer survivors when assessing their FCR, encourage them to disclose their concerns and fears, and provide tailored interventions in order to reduce FCR among them.

Funder

Iran University of Medical Sciences

Publisher

MDPI AG

Reference46 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. World Health Organization (2020, October 15). International Agency for Research on Cancer. Global Cancer Observatory. Available online: https://gco.iarc.fr/.

3. Transition to survivorship: Can there be improvement?;Fitch;Curr. Opin. Support Palliat. Care,2018

4. Cancer statistics, 2022;Siegel;CA Cancer J. Clin.,2022

5. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study;Drummond;J. Cancer Surviv.,2015

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3